Pacer Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,913
| Closed | -$515K | – | 2212 |
|
|
2021
Q3 | $515K | Buy |
1,913
+633
| +49% | +$170K | 0.01% | 1120 |
|
|
2021
Q2 | $329K | Sell |
1,280
-15
| -1% | -$3.86K | ﹤0.01% | 1247 |
|
|
2021
Q1 | $389K | Sell |
1,295
-32
| -2% | -$9.61K | 0.01% | 1145 |
|
|
2020
Q4 | $338K | Sell |
1,327
-1,545
| -54% | -$394K | 0.01% | 1110 |
|
|
2020
Q3 | $715K | Buy |
+2,872
| New | +$715K | 0.02% | 857 |
|
|
2020
Q1 | – | Sell |
-3,982
| Closed | -$1.29M | – | 957 |
|
|
2019
Q4 | $1.29M | Buy |
3,982
+1,831
| +85% | +$593K | 0.06% | 468 |
|
|
2019
Q3 | $588K | Buy |
2,151
+677
| +46% | +$185K | 0.01% | 963 |
|
|
2019
Q2 | $787K | Buy |
1,474
+441
| +43% | +$235K | 0.02% | 885 |
|
|
2019
Q1 | $521K | Sell |
1,033
-760
| -42% | -$383K | 0.01% | 568 |
|
|
2018
Q4 | $884K | Buy |
1,793
+236
| +15% | +$116K | 0.03% | 97 |
|
|
2018
Q3 | $1.42M | Buy |
1,557
+1,064
| +216% | +$973K | 0.05% | 479 |
|
|
2018
Q2 | $361K | Buy |
493
+83
| +20% | +$60.8K | 0.02% | 972 |
|
|
2018
Q1 | $654K | Buy |
+410
| New | +$654K | 0.04% | 647 |
|